Cargando…
Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and review
The management of multidrug-resistant human immunodeficiency virus (MDR HIV) infections in children is particularly challenging due to the lack of experience with new drugs. Dolutegravir, combined with an optimized antiretroviral background therapy, is promising for the treatment of MDR HIV and has...
Autores principales: | Wagner, N., Wyler-Lazarevic, C.A., Yerly, S., Samer, C., Peytavin, G., Posfay-Barbe, K.M., Calmy, A., Ambrosioni, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430707/ https://www.ncbi.nlm.nih.gov/pubmed/26082840 http://dx.doi.org/10.1016/j.nmni.2015.02.003 |
Ejemplares similares
-
Corrigendum to “Dolutegravir-based antiretroviral therapy in a severely overweight child with a multi-drug resistant human immunodeficiency virus infection. A case report and review” [New Microbes New Infect] 6 (2015) 1–4]
por: Wagner, N., et al.
Publicado: (2015) -
Stable HIV‐1 reservoirs on dolutegravir maintenance monotherapy: the MONODO study
por: Sculier, D, et al.
Publicado: (2018) -
Hyperglycemia After Dolutegravir-Based Antiretroviral Therapy
por: Hailu, Workagegnehu, et al.
Publicado: (2021) -
Adverse events of raltegravir and dolutegravir
por: Elzi, Luigia, et al.
Publicado: (2017) -
Severe Thrombocytopenia During Dolutegravir-containing Antiretroviral Therapy
por: Nakaharai, Kazuhiko, et al.
Publicado: (2017)